Personalized medicine takes into account the differences between patients’ normal and cancer cells DNA and enables therapy-matching based on the individual genomic profile. With this information, physicians can make more informed treatment decisions.
The genomic diagnostic tests identify the variants in the DNA that are the causes cancer, which are then analyzed and interpreted to determine relevant approved therapy options, or therapies undergoing clinical trials.
Patients and physicians are provided with an individual report containing targeted treatment options, based on the specific genomic profile of the cancer.
This is a valuable tool that will assist the physician in selecting the most appropriate personalized course of treatment for patients.